These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody. Kielbasa W, Helton DL. Cephalalgia; 2019 Sep 01; 39(10):1284-1297. PubMed ID: 30917684 [Abstract] [Full Text] [Related]
34. CGRP antagonists for decreasing migraine frequency: New options, long overdue. Bucklan J, Ahmed Z. Cleve Clin J Med; 2020 Apr 01; 87(4):211-218. PubMed ID: 32238376 [Abstract] [Full Text] [Related]
36. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review. Yuan H, Spare NM, Silberstein SD. Headache; 2019 Jul 01; 59 Suppl 2():20-32. PubMed ID: 31291020 [Abstract] [Full Text] [Related]
37. Antigens and Antibodies in Disease With Specifics About CGRP Immunology. Taylor FR. Headache; 2018 Nov 01; 58 Suppl 3():230-237. PubMed ID: 30187471 [Abstract] [Full Text] [Related]